Beacon Pointe Advisors, LLC

SEC CIK: 0001744317
Latest filing: Aug 18, 2026

SEC filings (opens in a new tab)

ITCI holding history

Intra-Cellular Therapies, Inc. in every 13F filed by Beacon Pointe Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ITCI overview All 13F holders of ITCI Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2022

Holdings of ITCI by Beacon Pointe Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−2,911−100.0%	Sold out	Holders
Q1 2024	2,911	$201.4K	<0.1%	+2,911	New	Holders
Q2 2022	0	$0	0.0%	−3,518−100.0%	Sold out	Holders
Q1 2022	3,518	$215.0K	<0.1%	+3,518	New	Holders